Arena Pharmaceuticals Pipeline

Pipeline

Robust pipeline of innovative oral drugs for large markets

Arena Pharmaceuticals
Pipeline

Pipeline

Robust pipeline of innovative oral drugs for large markets

 
Lorcarserin: Obesity
APD125: Insomnia
APD791: Arterial Thrombosis
APD916: Wakefulness Promoter
Niacin Receptor Agonist: Atherosclerosis
GDIR Agonists: Type 2 Diabetes
GPCR Modulator: Psychiatric Disorder











*The table above does not list all of our research programs.

Our product candidates have not been approved by the U.S. Food and Drug Administration or any international regulatory agency.

(NOTE: This page was last updated: June 5, 2008.)

Back To Top

---
Copyright 2007
Terms and Conditions | Privacy Statement
  Contact Us  Site Map |   Search